Skip to main content
. 2016 Jun 28;15:92. doi: 10.1186/s12933-016-0404-7

Fig. 2.

Fig. 2

Proportions of CAD progression according to the number of the metabolic syndrome (MS) components present. a Proportion of patients with CACS progression. b Proportions of progression evaluated by the degree of coronary stenosis. c Proportions of the development of vulnerable plaque, according to the numbers of components of MS